Harmalol hydrochloride

Tarpley M, et al. Identification of harmine and ?-carboline analogs from a high-throughput screen of an approved drug collection; profiling as differential inhibitors of DYRK1A and monoamine oxidase A and for in vitro and in vivo anti-cancer studies. Eur J Pharm Sci. 2021;162:105821. Brierley DI, et al. Developments in harmine pharmacology--implications for ayahuasca use and drug-dependence treatment. Prog Neuropsychopharmacol Biol Psychiatry. 2012;39(2):263-272. Tse SY, et al. Antioxidative properties of harmane and beta-carboline alkaloids. Biochem Pharmacol. 1991;42(3):459-46 El Gendy MA, et al. Harmaline and harmalol inhibit the carcinogen-activating enzyme CYP1A1 via transcriptional and posttranslational mechanisms. Food Chem Toxicol. 2012;50(2):353-362. Han E S, et al. Inhibition of Glutamate-Induced Change in Mitochondrial Membrane Permeability in PC12 cells by 1-Methylated ?-carbolines. The Korean Society of Applied Pharmacology. 2003;11(2): 112-118.